Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cher Y. Enderby
Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension
Therapeutic Advances in Chronic Disease
Medicine
Related publications
Rapid Transition From Inhaled Iloprost to Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Treatment Satisfaction Is Associated With Improved Quality of Life in Patients Treated With Inhaled Treprostinil for Pulmonary Arterial Hypertension
Health and Quality of Life Outcomes
Medicine
Environmental
Public Health
Occupational Health
Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension From Intravenous Epoprostenol to Intravenous Treprostinil
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Effects of Inhaled Aviptadil (Vasoactive Intestinal Peptide) in Patients With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension in Patients Treated With Interferon: TABLE 1
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Inhaled Iloprost for Treatment of Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
Motivations of Patients With Pulmonary Arterial Hypertension to Participate in Randomized Clinical Trials
Clinical Trials
Medicine
Pharmacology
Platelet Indices in Patients With Pulmonary Arterial Hypertension
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology